
Republican Senators Introduce Bill Mandating Federal Study on Medicaid Hospital Costs Linked to Marijuana Use
Republican Senators Ted Budd and Pete Ricketts have introduced a bill requiring the federal government to report on Medicaid hospital costs linked to marijuana use, with findings due to Congress within a year
Key Points
- 1Senators Ted Budd and Pete Ricketts introduced the Marijuana Impact on Medicaid Act of 2026
- 2The bill requires HHS to report on Medicaid hospital costs related to marijuana use
- 3Congress would receive the report and recommendations within one year of the bill's enactment
- 4Senators argue increased marijuana potency poses a public health risk
- 5Previous similar amendments by Budd were not considered on the Senate floor
A new bill introduced by Republican Senators Ted Budd of North Carolina and Pete Ricketts of Nebraska would require the Department of Health and Human Services (HHS) to track and report on hospital costs attributed to marijuana use under the Medicaid program. The Marijuana Impact on Medicaid Act of 2026 calls for data collection on federal and state expenditures for inpatient, outpatient, and emergency room services related to cannabis. The findings would be presented to Congress within one year of the bill's enactment, along with any legislative or administrative recommendations from the HHS secretary
Senator Budd emphasized the motivation behind the legislation, stating, “The health consequences tied to marijuana use are serious, leading to increased risk for heart attacks, strokes, psychotic disorders and further addictions.” He argued that Congress must prioritize public health and safety when making decisions about marijuana policy. Budd further asserted, “Millions of Americans rely on Medicaid healthcare benefits, and my legislation will ensure Congress understands the dangers of this drug and its impact on federally funded health programs.”
Senator Ricketts echoed these concerns, highlighting the growing potency of cannabis products. “The average THC potency in marijuana has more than tripled since 1995,” Ricketts said. He called high-potency marijuana an “increasingly concerning threat to public health,” and stressed the importance of understanding the implications for the healthcare system. The bill’s approach mirrors previous amendments filed by Budd addressing the same issue, which were not taken up on the Senate floor
Calls for increased scrutiny of marijuana’s impact on public health have been a consistent theme among legalization opponents, who often cite rising hospital visits linked to cannabis use. In addition to this bill, Budd and other GOP senators previously urged former President Donald Trump not to reschedule marijuana at the federal level. In 2024, Budd also questioned officials about enforcement of marijuana prohibition as an Indian tribe in North Carolina prepared to launch recreational cannabis sales
From the OG Lab newsroom perspective, this legislative move reflects ongoing tensions in the national cannabis debate, particularly around public health costs and federal oversight. As states continue to expand access to legal marijuana, efforts like the Marijuana Impact on Medicaid Act signal a push for more data-driven policymaking. The outcome of this bill could influence both future cannabis legislation and how healthcare costs associated with marijuana are tracked and addressed


